27 related articles for article (PubMed ID: 6580255)
1. Exploring the mechanism of resistance to vincristine in breast cancer cells using transcriptome sequencing technology.
Chen Y; Yang L; Wang C; Wang C
Oncol Lett; 2023 Dec; 26(6):502. PubMed ID: 37920438
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Newly Established Homoharringtonine- (HHT-) Resistant Cell Lines and Mechanisms of Resistance.
Li F; Ling Q; Hu C; Wang H; Ye W; Li X; Zhang X; Lin X; Wei W; Huang X; Qian Y; Zhuang H; Jin J; Lu Y
J Oncol; 2022; 2022():2813938. PubMed ID: 36081671
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?
Rumjanek VM; Vidal RS; Maia RC
Biosci Rep; 2013 Nov; 33(6):. PubMed ID: 24070327
[TBL] [Abstract][Full Text] [Related]
4. Resistance to thapsigargin-induced intracellular calcium mobilization in a multidrug resistant tumour cell line.
Wagner-Souza K; Echevarria-Lima J; Rodrigues LA; Reis M; Rumjanek VM
Mol Cell Biochem; 2003 Oct; 252(1-2):109-16. PubMed ID: 14577583
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo modulation by rhizoxin of non-P-glycoprotein-mediated vindesine resistance.
Arioka H; Nishio K; Heike Y; Abe S; Saijo N
J Cancer Res Clin Oncol; 1997; 123(4):195-200. PubMed ID: 9177491
[TBL] [Abstract][Full Text] [Related]
6. Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro.
Hill BT
Cytotechnology; 1993; 12(1-3):265-88. PubMed ID: 7765329
[TBL] [Abstract][Full Text] [Related]
7. Relationship between multidrug resistant gene expression and multidrug resistant-reversing effect of MS-209 in various tumor cells.
Baba M; Nakanishi O; Sato W; Saito A; Miyama Y; Yano O; Shimada S; Fukazawa N; Naito M; Tsuruo T
Cancer Chemother Pharmacol; 1995; 36(5):361-7. PubMed ID: 7634376
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of the amplified mdr1 gene in revertants of multidrug-resistant human myelogenous leukemia K562 occurs without loss of amplified DNA.
Sugimoto Y; Roninson IB; Tsuruo T
Mol Cell Biol; 1987 Dec; 7(12):4549-52. PubMed ID: 3481435
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of multidrug resistance and implications for therapy.
Tsuruo T
Jpn J Cancer Res; 1988 Mar; 79(3):285-96. PubMed ID: 3131279
[No Abstract] [Full Text] [Related]
10. Expression of P-glycoprotein mRNA in human gastric tumors.
Sugimoto Y; Asami N; Tsuruo T
Jpn J Cancer Res; 1989 Oct; 80(10):993-9. PubMed ID: 2575610
[TBL] [Abstract][Full Text] [Related]
11. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies.
Hamada H; Tsuruo T
Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7785-9. PubMed ID: 2429319
[TBL] [Abstract][Full Text] [Related]
12. Increase in the level of P-glycoprotein mRNA expression in multidrug-resistant K562 cell lines treated with sodium butyrate is not accompanied with erythroid differentiation.
Shibata H; Kanamaru R; Sato T; Ishioka C; Konishi Y; Ishikawa A; Wakui A; Tsuruo T
Jpn J Cancer Res; 1990 Dec; 81(12):1214-7. PubMed ID: 1980493
[TBL] [Abstract][Full Text] [Related]
13. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities.
Devault A; Gros P
Mol Cell Biol; 1990 Apr; 10(4):1652-63. PubMed ID: 1969610
[TBL] [Abstract][Full Text] [Related]
14. Establishment and properties of vincristine-resistant human myelogenous leukemia K562.
Tsuruo T; Iida H; Ohkochi E; Tsukagoshi S; Sakurai Y
Gan; 1983 Oct; 74(5):751-8. PubMed ID: 6580255
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones.
Tsuruo T; Iida-Saito H; Kawabata H; Oh-hara T; Hamada H; Utakoji T
Jpn J Cancer Res; 1986 Jul; 77(7):682-92. PubMed ID: 3091555
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of vincristine resistance in vincristine resistant human myelogenous leukemia K562.
Tsuruo T; Oh-Hara T; Saito H
Anticancer Res; 1986; 6(4):637-41. PubMed ID: 3463241
[TBL] [Abstract][Full Text] [Related]
17. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
18. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
Tsuruo T
Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516
[TBL] [Abstract][Full Text] [Related]
19. Acquisition of multiple drug resistance by CCRF-CEM cells selected for different degrees of resistance to vincristine.
Conter V; Beck WT
Cancer Treat Rep; 1984 Jun; 68(6):831-9. PubMed ID: 6539648
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
